Results 11 to 20 of about 836,132 (267)

Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples

BMC Research Notes, 2019
Objective Dried blood spots (DBSs) can be used as an alternative to serum samples because they are easily collected and can be transported without refrigeration to reference laboratories for diagnosis.
Livia Melo Villar, Helena Medina Cruz, Raissa Martins Deodato, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Geane Lopes Flores, Lia Laura Lewis-Ximenez   +6 more
doaj   +1 more source

The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth [PDF]

Human Vaccines & Immunotherapeutics
Pierre Van Damme, Greet Hendrickx, Sakshi Jindal, Sara Valckx, Alex Vorsters, Silvia Bino, Paolo Bonanni, Maria Buti, Stéphane Chevaliez, Sandra Dudareva, Angela Domínguez, Ivana Dragojević, Sharon Hutchinson, Wolfgang Jilg, Mark Kane, Mira Kojouharova, Daniel Lavanchy, David FitzSimons, Sema Mandal, Rui Tato Marinho, Mojca Matičič, Vana Papaevangelou, Tatjana Reić, Françoise Roudot-Thoraval, Daniel Shouval, Thomas Vanwolleghem, John W. Ward   +26 more
doaj   +2 more sources

The hidden effects of COVID-19 on HIV services in Zanzibar: country report

AIDS Research and Therapy, 2023
The COVID-19 pandemic has had a major effect on HIV-related healthcare services. Zanzibar has experienced several interruptions of HIV services in the areas of testing and counselling, prevention of mother-to-child transmission of HIV, key population ...
Mansour Maulid Mshenga, Farhat Jowhar Khalid, Shaaban Hassan Haji, Tatu Bilali Ali, Khadija Abbas Mohamed, Damian Jeremia Damian   +5 more
doaj   +1 more source

Automated quality control for a molecular surveillance system

BMC Bioinformatics, 2018
Background Molecular surveillance and outbreak investigation are important for elimination of hepatitis C virus (HCV) infection in the United States. A web-based system, Global Hepatitis Outbreak and Surveillance Technology (GHOST), has been developed ...
Seth Sims, Atkinson G. Longmire, David S. Campo, Sumathi Ramachandran, Magdalena Medrzycki, Lilia Ganova-Raeva, Yulin Lin, Amanda Sue, Hong Thai, Alexander Zelikovsky, Yury Khudyakov   +10 more
doaj   +1 more source

P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS

Annals of Hepatology, 2023
Introduction and Objectives: Hepatitis B Virus (HBV) has been a cause of acute and chronic hepatitis with progression to cirrhosis and hepatocellular carcinoma.
Alanna Calheiros Santos, Juliana Gil Melgaço, Lucas Lima da Silva, Vanessa Duarte da Costa, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, Vanessa Salete de Paula, Livia Melo Villar   +9 more
doaj   +1 more source

Identification of recent cases of hepatitis C virus infection using physical-chemical properties of hypervariable region 1 and a radial basis function neural network classifier

BMC Genomics, 2017
Background Identification of acute or recent hepatitis C virus (HCV) infections is important for detecting outbreaks and devising timely public health interventions for interruption of transmission.
James Lara, Mahder Teka, Yury Khudyakov
doaj   +1 more source

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

Harm Reduction Journal, 2023
Background The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention.
Graham Shaw, Robin Schaefer, Heather-Marie A Schmidt, Annie Madden, Judy Chang, Antons Mozalevskis, Busisiwe Msimanga-Radebe, Nabeel Mangadan Konath, Annette Verster, Rachel Baggaley, Michelle Rodolph, Virginia Macdonald   +11 more
doaj   +1 more source

Best practices for engaging with affected communities: chronic hepatitis B as a case study

Infectious Diseases of Poverty
Hepatitis B is the single most common cause of liver cancer, affecting > 250 million people worldwide (mostly in resource limited communities) and killing > 1 million people annually. The condition is marked by poor rates of diagnosis (14%) and treatment
Thomas Tu, Nafisa Yussf, Lien Tran, Kim Ngo, Su Wang, Adi Mondel, Isabelle Purcell, Jacki Chen, Wendy Lo, Bright Ansah, Kenneth Kabagambe, Soumen Basu, Dee Lee, Supa Chantschool, Chris Munoz, Ivana Dragojevic, Marko Korenjak, Fiona Borondy-Jenkins, Yasmin Ibrahim, Beatrice Zovich, Chari Cohen   +20 more
doaj   +1 more source

Barriers to accessing hepatitis B medication: a qualitative study from the USA and Canada

BMJ Open
Objectives To collect and document the numerous barriers that people living with hepatitis B (PLHB) encounter when trying to access their hepatitis B virus (HBV) medications.Design Researchers collected qualitative data through 24 online interviews.
Sophie Jacob, Michaela Jackson, Yasmin Ibrahim, Catherine Freeland, Beatrice Zovich, Chari Cohen   +5 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source